View in EDS

Parsonage–Turner Syndrome and Vocal Fold Paresis Following Soberana 2 FINLAY‐FR‐2 COVID‐19 Vaccination: A Case Report

Saved in:
Bibliographic Details
Title: Parsonage–Turner Syndrome and Vocal Fold Paresis Following Soberana 2 FINLAY‐FR‐2 COVID‐19 Vaccination: A Case Report
Authors: Amir‐Hassan Bordbari, Negar Heidari, Narges Karimi
Source: Clinical Case Reports, Vol 13, Iss 11, Pp n/a-n/a (2025)
Publisher Information: Wiley, 2025.
Publication Year: 2025
Collection: LCC:Medicine
LCC:Medicine (General)
Subject Terms: brachial plexus neuritis, COVID‐19 vaccines, Parsonage–Turner syndrome, vocal fold paralysis, Medicine, Medicine (General), R5-920
Description: ABSTRACT This case report presents a 58‐year‐old male who developed Parsonage–Turner syndrome (PTS) and vocal cord paresis after receiving the Soberana 2 FINLAY‐FR‐2 COVID‐19 vaccine. The patient experienced escalating pain and weakness in both shoulders and upper limbs after each vaccine dose, with subsequent neurological symptoms including headaches, dysphagia, hoarseness, numbness, dyspnea, and chest discomfort. Neurological examinations and electrodiagnostic studies confirmed upper trunk brachial plexopathy along with vocal fold paresis. This patient was treated with intravenous methylprednisolone. Despite therapeutic intervention, the patient exhibited persistent neurological deficits during follow‐up.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2050-0904
Relation: https://doaj.org/toc/2050-0904
DOI: 10.1002/ccr3.71348
Access URL: https://doaj.org/article/7d233b458ead426780bdaf62ca8a6ee5
Accession Number: edsdoj.7d233b458ead426780bdaf62ca8a6ee5
Database: Directory of Open Access Journals
Description
Abstract:ABSTRACT This case report presents a 58‐year‐old male who developed Parsonage–Turner syndrome (PTS) and vocal cord paresis after receiving the Soberana 2 FINLAY‐FR‐2 COVID‐19 vaccine. The patient experienced escalating pain and weakness in both shoulders and upper limbs after each vaccine dose, with subsequent neurological symptoms including headaches, dysphagia, hoarseness, numbness, dyspnea, and chest discomfort. Neurological examinations and electrodiagnostic studies confirmed upper trunk brachial plexopathy along with vocal fold paresis. This patient was treated with intravenous methylprednisolone. Despite therapeutic intervention, the patient exhibited persistent neurological deficits during follow‐up.
ISSN:20500904
DOI:10.1002/ccr3.71348